Epstein Secrets

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

AL EXAMINER OF THE CITY OF NEW YORK STATE OF NEW YORK ) SS.: COUNTY OF NEW YORK ) CERTIFICATION AS A BUSINESS RECORD I have been delegated by Barbara A. Sampson, M.D.-Ph.D., Chief Medical Examiner, to certify and authenticate records of the Office of Chief Medical Examiner of the City of New York ("OCME") p

thetic Cernabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquld Chromatography/Tandem Mass Spectrometry CITFtAP (LC-MS/MS QTRAP) for Comnnmstd 4-cyano-CUMYL-BINACA 4-fluoro-MOMB-BINACA 5-fluoro-EDNIB-PINACA 5-fluoro-MOMB-PICA 5-fluoro-MDMB-PINACA 5-fluoro- EMB-P

signed by on Aug 20, 2019 05:41:27 PM SDNY_00014096 Page 0/ EFTA00137984 OFFICE OF CHIEF MEDICAL EXAMINER 520 First Avenue, New York, NY 10016 Barbara A. Sampson, MD-Ph.D., Chief Medical Examiner Department of Forensic Pathology Forensic Anthropology Unit (212)447-2763 [email protected] M-19-19432

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

Field Office EFTA00063517 OFFICE OF CHIEF MEDICAL EXAMINER OF THE CITY OF NEW YORK CERTIFICATION AS A BUSINESS RECORD I have been delegated by Barbara A. Sampson, M.D.- Ph.D., Chief Medical Examiner, to certify and authenticate records of the Office of Chief Medical Examiner of the City of New York ("OCME")

ynthetic Carnabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatographyrfandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Comm-km(1 Bal .Old command Eat-Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-ftuoro-PADMB-BINACA 0.10 ng/mL

ically signed by Rebecca Folkerth on Aug 20, 2019 05:41:27 PM EFTA00049625 OFFICE OF CHIEF MEDICAL EXAMINER 520 First Avenue, New York, NY 10016 Barbara A. Sampson, MD-Ph.D., Chief Medical Examiner Department of Forensic Pathology Forensic Anthropology Unit (212)447-2763 [email protected] M-19-19432

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n

ates of treatment: Signature /Yid flizil• Relationship e-A 42' Date EFTA00133111 • . EFTA00133112 NYC Office of Chief Medical Examiner Barbara A. Sampson, M.D.-Ph.D. Chief Medical Examiner Name of Decedent: Report Dale .4 Time: Place of Death: 421E 28th Street Medico-Legal investigations New Yak